Form 4: Vireo Growth CFO Macdonald Receives 3.2 Million Subordinate Voting Shares

Tyson Macdonald, CFO of Vireo Growth Inc., reports the acquisition of 3,200,000 subordinate voting shares on December 17, 2024, under the company's equity incentive plan.

Summary

• On December 17, 2024, Tyson Macdonald, the Chief Financial Officer of Vireo Growth Inc., acquired 3,200,000 subordinate voting shares.
• The shares were granted under the Vireo Health International Inc. 2019 Equity Incentive Plan, as amended.
• The shares vest on the grant date.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard reporting of equity compensation. The grant itself is a positive sign of investment in the CFO, but the filing is routine.

Positives

• The grant of shares to the CFO aligns his interests with those of the shareholders.
• The vesting of shares on the grant date suggests immediate alignment and motivation.

Industry Context

Equity grants are a common practice in the cannabis industry to attract and retain key executives, aligning their interests with the company's long-term performance.

Comparison to Industry Standards

• Equity compensation packages for CFOs in the cannabis industry vary widely depending on the company's size, stage, and performance.
• Comparing Macdonald's equity grant to those of CFOs at similar-sized cannabis companies (e.g., Curaleaf, Green Thumb Industries) would provide a benchmark for assessing its relative value.
• Typical equity grants for CFOs in growth-oriented companies often include a mix of stock options and restricted stock units (RSUs) with vesting schedules tied to performance milestones or continued employment.

Stakeholder Impact

• The equity grant could be viewed positively by shareholders as it aligns the CFO's interests with the company's success.
• Employees may see this as a positive sign of the company's commitment to its leadership team.

Key Dates